SAN FRANCISCO, May 08, 2017 -- Today Zephyr Health, the leading Insights-as-a-Service company, announced it is certified on Veeva CRM MyInsights, an innovative new data visualization capability launched today at the 2017 Veeva Global Commercial & Medical Summit. Veeva CRM MyInsights enables Zephyr IlluminateTM to deliver tailored visualizations of its precise and predictive data insights in Veeva CRM.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/647ed474-fc6e-43f4-8713-1acb39340317
Veeva unveiled a new certification program that offers customers an ecosystem of providers trained to create pre-built dashboards and custom data visualizations. Zephyr Health is one of the first to join the growing Veeva CRM MyInsights certified provider ecosystem.
“Veeva CRM MyInsights gives customers the ability to visualize their data any way they want and embed it right at the point of action,” said Arno Sosna, general manager of Veeva CRM. “Flexible and easy to use, Veeva CRM MyInsights can be quickly developed or extended for tailored data visualizations that drive the best actions at the right time.”
Zephyr Illuminate helps Life Sciences companies engage the right physicians, accounts and institutions using precise and predictive insights from thousands of global health data sources - public, private and vendor - including Veeva OpenData and Veeva CRM. From pre-launch to product maturity, life sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles.
These tailored, high-impact analytics and visualizations are now available for Veeva CRM MyInsights, with links to detailed healthcare provider and institution profiles in Zephyr Illuminate. Life Sciences users can easily create or customize data visualizations to boost their productivity using these relevant and actionable insights.
"Next-generation commercial excellence takes an ecosystem of partners who are capable of bringing innovation to Life Sciences’ commercial teams,” said Lance Scott, President and CEO of Zephyr Health. “The integration of Zephyr Illuminate’s precise and predictive insights with Veeva CRM MyInsights will translate brand strategy into field productivity and customer engagement.”
About Zephyr Health
Zephyr Health helps Life Sciences companies – pharmaceutical, biotech, medical device and diagnostics – engage the right physicians, accounts and institutions using insights from global health data. Zephyr Illuminate™ is a leading Insights-as-a-Service solution that integrates thousands of data sources to create precise and predictive insights. From pre-launch to product maturity, Life Sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers, and Icon Ventures. For more information, please visit: www.zephyrhealth.com.
Press Contact: [email protected] Terri Clevenger Continuum Health Communications (203) 856-4326


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Instagram Outage Disrupts Thousands of U.S. Users
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 



